Home

NASDAQ:MRVI Stock Quote

2.2100
-0.1500 (-6.36%)

Maravai Lifesciences Holdings Inc is a biotechnology company that specializes in providing critical products and services for life sciences research and drug development

The company focuses on the supply of essential reagents and tools that support various applications, including mRNA production, immunotherapy, and cell and gene therapies. By offering a range of high-quality solutions, Maravai enables researchers and pharmaceutical companies to accelerate scientific discovery and the development of innovative therapies, playing a vital role in advancing public health and medicine.

SummaryNewsPress ReleasesChartHistoricalFAQ
Previous Close2.360
Open2.270
Bid2.140
Ask2.440
Day's Range2.190 - 2.340
52 Week Range2.070 - 11.56
Volume3,085,187
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume3,891,661

News & Press Releases

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRVI
By The Rosen Law Firm PA · Via GlobeNewswire · March 30, 2025
MRVI Class Action Alert: Kessler Topaz Meltzer & Check, LLP Reminds Maravai LifeSciences Holdings, Inc. (MRVI) Shareholders of Securities Fraud Class Action Lawsuit Deadline
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · March 30, 2025
MRVI Class Action Alert: Kessler Topaz Meltzer & Check, LLP Reminds Maravai LifeSciences Holdings, Inc. (MRVI) Shareholders of Securities Fraud Class Action Lawsuit Deadline
RADNOR, PA - March 30, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai”) (NASDAQ: MRVI) on behalf of those who purchased or otherwise acquired Maravai securities between August 7, 2024, and February 24, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is May 5, 2025.
Via TheNewswire.com · March 30, 2025
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holidngs, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVI
NEW YORK, March 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
By Pomerantz LLP · Via GlobeNewswire · March 30, 2025
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Maravai LifeSciences To Contact Him Directly To Discuss Their Options
By Faruqi & Faruqi LLP · Via GlobeNewswire · March 30, 2025
MRVI SHAREHOLDER ACTION ALERT: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Maravai LifeSciences Holdings, Inc. (MRVI) and Lead Plaintiff Deadline on May 5, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · March 29, 2025
MRVI SHAREHOLDER ACTION ALERT: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Maravai LifeSciences Holdings, Inc. (MRVI) and Lead Plaintiff Deadline on May 5, 2025
NEW YORK - March 29, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) on behalf of investors that purchased or otherwise acquired Maravai securities between August 7, 2024 and February 24, 2025 (the “Class Period”).
Via TheNewswire.com · March 29, 2025
Kessler Topaz Meltzer & Check, LLP Notifies Maravai LifeSciences Holdings, Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · March 28, 2025
Kessler Topaz Meltzer & Check, LLP Notifies Maravai LifeSciences Holdings, Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit
RADNOR, PA - March 28, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai”) (NASDAQ: MRVI) on behalf of those who purchased or otherwise acquired Maravai securities between August 7, 2024, and February 24, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is May 5, 2025.
Via TheNewswire.com · March 28, 2025
MRVI DEADLINE FOR LEADERSHIP is May 5, 2025 in a Securities Fraud Lawsuit Contact Kaplan Fox
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · March 28, 2025
MRVI DEADLINE FOR LEADERSHIP is May 5, 2025 in a Securities Fraud Lawsuit Contact Kaplan Fox
NEW YORK - March 28, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) on behalf of investors that purchased or otherwise acquired Maravai securities between August 7, 2024 and February 24, 2025 (the “Class Period”).
Via TheNewswire.com · March 28, 2025
ROSEN, A RANKED AND LEADING FIRM, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRVI
NEW YORK, March 27, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · March 27, 2025
MRVI CLASS ACTION DEADLINE: Kaplan Fox Reminds Investors of a Class Action Lawsuit against Maravai LifeSciences Holdings, Inc. (MRVI) and Lead Plaintiff Deadline on May 5, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · March 27, 2025
MRVI CLASS ACTION DEADLINE: Kaplan Fox Reminds Investors of a Class Action Lawsuit against Maravai LifeSciences Holdings, Inc. (MRVI) and Lead Plaintiff Deadline on May 5, 2025
NEW YORK - March 27, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) on behalf of investors that purchased or otherwise acquired Maravai securities between August 7, 2024 and February 24, 2025 (the “Class Period”).
Via TheNewswire.com · March 27, 2025
MRVI Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of May 5, 2025 Deadline in Securities Fraud Class Action Lawsuit Against Maravai LifeSciences Holdings, Inc. (MRVI)
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · March 26, 2025
MRVI Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of May 5, 2025 Deadline in Securities Fraud Class Action Lawsuit Against Maravai LifeSciences Holdings, Inc. (MRVI)
RADNOR, PA - March 26, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai”) (NASDAQ: MRVI) on behalf of those who purchased or otherwise acquired Maravai securities between August 7, 2024, and February 24, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is May 5, 2025.
Via TheNewswire.com · March 26, 2025
Faruqi & Faruqi Reminds Maravai Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025 - MRVI
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Maravai LifeSciences To Contact Him Directly To Discuss Their Options
By Faruqi & Faruqi LLP · Via GlobeNewswire · March 26, 2025
MARAVAI LIFESCIENCES DEADLINE FOR LEADERSHIP is May 5, 2025 in a Securities Fraud Lawsuit Contact Kaplan Fox & Kilsheimer LLP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · March 26, 2025
MARAVAI LIFESCIENCES DEADLINE FOR LEADERSHIP is May 5, 2025 in a Securities Fraud Lawsuit Contact Kaplan Fox & Kilsheimer LLP
NEW YORK - March 26, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) on behalf of investors that purchased or otherwise acquired Maravai securities between August 7, 2024 and February 24, 2025 (the “Class Period”).
Via TheNewswire.com · March 26, 2025
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVI
NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
By Pomerantz LLP · Via GlobeNewswire · March 26, 2025
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Skyworks Solutions, Maravai, AppLovin, and Manhattan Associates and Encourages Investors to Contact the Firm
NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Skyworks Solutions, Inc. (NASDAQ:SWKS), Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), AppLovin Corporation (NASDAQ:APP), and Manhattan Associates, Inc. (NASDAQ:MANH). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · March 25, 2025
MRVI DEADLINE: Investors of Maravai LifeSciences Holdings, Inc. (MRVI) Are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on May 5, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · March 25, 2025
MRVI DEADLINE: Investors of Maravai LifeSciences Holdings, Inc. (MRVI) Are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on May 5, 2025
NEW YORK - March 25, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) on behalf of investors that purchased or otherwise acquired Maravai securities between August 7, 2024 and February 24, 2025 (the “Class Period”).
Via TheNewswire.com · March 25, 2025
Breaking Down Maravai LifeSciences: 4 Analysts Share Their Viewsbenzinga.com
Via Benzinga · March 25, 2025
Trump Media & Technology Group, BitFuFu, Mobileye Global And Other Big Stocks Moving Higher On Tuesdaybenzinga.com
Via Benzinga · March 25, 2025